We are live on ! Find out more
RXST icon

RxSight
RXST

49 hedge funds and large institutions have $110M invested in RxSight in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 7

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

9% more funds holding

Funds holding: 45 → 49 (+4)

1.9% more ownership

Funds ownership: 31.92% → 33.83% (+1.9%)

1% more capital invested

Capital invested by funds: $108M → $110M (+$1.43M)

Holders
49
Holders Change
+4
Holders Change %
+8.89%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.73M
2
EI
EAM Investors
California
+$2.32M
3
State Street
State Street
Massachusetts
+$1.79M
4
BM
Bridger Management
New York
+$1.75M
5
PHP
Parkman Healthcare Partners
Connecticut
+$1.52M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.73M
2
MF
Magnetar Financial
Illinois
-$1.75M
3
BFM
Boothbay Fund Management
New York
-$329K
4
SW
SVB Wealth
Massachusetts
-$251K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$43M – – –
BlackRock
2
BlackRock
New York
$13.3M +$2.73M +206,951 +28%
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.46M +$438K +33,242 +5%
Millennium Management
4
Millennium Management
New York
$7.17M -$5.73M -434,812 -46%
BM
5
Bridger Management
New York
$4.67M +$1.75M +132,832 +67%
CAM
6
Cresset Asset Management
Illinois
$4.45M – – –
State Street
7
State Street
Massachusetts
$4.04M +$1.79M +135,935 +90%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.21M +$82.9K +6,287 +3%
EI
9
EAM Investors
California
$2.48M +$2.32M +176,270 New
SC
10
Sessa Capital
New York
$2.31M – – –
RI
11
RTW Investments
New York
$2.11M – – –
Northern Trust
12
Northern Trust
Illinois
$2.1M +$203K +15,366 +11%
PHP
13
Parkman Healthcare Partners
Connecticut
$1.62M +$1.52M +115,000 New
EGI
14
EAM Global Investors
California
$1.4M +$1.31M +99,317 New
N
15
Nuveen
North Carolina
$918K +$532K +40,301 +162%
BFS
16
Bradley Foster & Sargent
Connecticut
$789K +$380K +28,777 +105%
Russell Investments Group
17
Russell Investments Group
United Kingdom
$762K +$715K +54,246 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$722K +$166K +12,611 +33%
Charles Schwab
19
Charles Schwab
California
$684K +$80.5K +6,106 +14%
IWM
20
IHT Wealth Management
Illinois
$578K +$541K +41,050 New
Bank of America
21
Bank of America
North Carolina
$517K +$179K +13,569 +59%
Citadel Advisors
22
Citadel Advisors
Florida
$422K +$396K +29,988 New
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$333K +$149K +11,312 +92%
BFM
24
Boothbay Fund Management
New York
$330K -$329K -24,974 -52%
Wells Fargo
25
Wells Fargo
California
$318K -$170K -12,900 -36%
1
2 3

RXST Hedge Fund Activity: Q2 2022 in Review

49 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2022, worth a combined $110M — up 1.3% from $108M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new RXST positions and 7 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $2.73M. The largest seller was Millennium Management, cutting an estimated $5.73M.

  • 49 institutional investors held RxSight (RXST) as of Q2 2022, up from 45 in Q1 2022.
  • Funds reported $110M of RxSight stock for Q2 2022, up 1.3% quarter-over-quarter.
  • 12 funds opened new RxSight positions in Q2 2022 and 7 closed out, a net change of +5 holders.
  • The largest RxSight buyer in Q2 2022 was BlackRock, an estimated $2.73M added.
  • The largest RxSight seller in Q2 2022 was Millennium Management, an estimated $5.73M sold.

Based on aggregated 13F filings for Q2 2022.